ICICI Securities: Insecticides India Q2 Review- Higher Focus On Cash Collection
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
ICICI Securities Report
Three takeaways from Insecticides India Ltd.’s Q2FY21 earnings:
1. Uneven rainfall and less pest infestation resulted in revenue decline of 9.4%. Branded products revenue declined 15%. Higher focus on cash collections also impacted revenue growth.
2. company has reduced net working capital days to 115 at H1 FY21-end versus 184 at FY20-end. The company has also repaid its entire debt with better cash collections.
(3) Ebitda margin declined 170 basis points YoY due to inferior product mix and negative operating leverage.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the brokerage and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.